Paper39022452
Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.
Nath AG and 6 others. J Lipids, 2024. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications. Papers, record 39022452. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39022452
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References125
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23470001 | Nanostructured cubosomes as advanced drug delivery system. | Curr Pharm Des | 2013 | https://conductscience.org/library/papers/23470001 | PubMed |
| 2 | 33621518 | Development, Optimization, and Antifungal Assessment of Ocular Gel Loaded With Ketoconazole Cubic Liquid Crystalline Nanoparticles. | J Pharm Sci | 2021 | https://conductscience.org/library/papers/33621518 | PubMed |
| 3 | 34403750 | Topical drug delivery: History, percutaneous absorption, and product development. | Adv Drug Deliv Rev | 2021 | https://conductscience.org/library/papers/34403750 | PubMed |
| 4 | 35808060 | A Versatile Nanocarrier-Cubosomes, Characterization, and Applications. | Nanomaterials (Basel) | 2022 | https://conductscience.org/library/papers/35808060 | PubMed |
| 5 | 30518267 | Management of bacterial skin and skin structure infections with polymicrobial etiology. | Expert Rev Anti Infect Ther | 2019 | https://conductscience.org/library/papers/30518267 | PubMed |
| 6 | 29990862 | Emerging landscape in psoriasis management: From topical application to targeting biomolecules. | Biomed Pharmacother | 2018 | https://conductscience.org/library/papers/29990862 | PubMed |
| 7 | 36559196 | Tailoring Lipid-Based Drug Delivery Nanosystems by Synchrotron Small Angle X-ray Scattering. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36559196 | PubMed |
| 8 | 31626916 | Fungal keratitis: Pathogenesis, diagnosis and prevention. | Microb Pathog | 2020 | https://conductscience.org/library/papers/31626916 | PubMed |
| 9 | 36736676 | Hair regrowth boosting via minoxidil cubosomes: Formulation development, in vivo hair regrowth evaluation, histopathological examination and confocal laser microscopy imaging. | Int J Pharm | 2023 | https://conductscience.org/library/papers/36736676 | PubMed |
| 10 | 25590022 | Ocular drug delivery systems: An overview. | World J Pharmacol | 2013 | https://conductscience.org/library/papers/25590022 | PubMed |
| 11 | 33527709 | The impact of air pollution on skin and related disorders: A comprehensive review. | Dermatol Ther | 2021 | https://conductscience.org/library/papers/33527709 | PubMed |
| 12 | 37390565 | Psoriasis and skin cancer - Is there a link? | Int Immunopharmacol | 2023 | https://conductscience.org/library/papers/37390565 | PubMed |
| 13 | 36604813 | Syringeable atorvastatin loaded eugenol enriched PEGylated cubosomes in-situ gel for the intra-pocket treatment of periodontitis: statistical optimization and clinical assessment. | Drug Deliv | 2023 | https://conductscience.org/library/papers/36604813 | PubMed |
| 14 | 35169601 | Vitiligo following COVID-19: A case report and review of pathophysiology. | JAAD Case Rep | 2022 | https://conductscience.org/library/papers/35169601 | PubMed |
| 15 | 33440514 | Biomimetic Lipid-Based Nanosystems for Enhanced Dermal Delivery of Drugs and Bioactive Agents. | ACS Biomater Sci Eng | 2017 | https://conductscience.org/library/papers/33440514 | PubMed |
| 16 | 35636617 | Recent advances in versatile inverse lyotropic liquid crystals. | J Control Release | 2022 | https://conductscience.org/library/papers/35636617 | PubMed |
| 17 | 30081623 | Microfluidics Synthesis of Gene Silencing Cubosomes. | ACS Nano | 2018 | https://conductscience.org/library/papers/30081623 | PubMed |
| 18 | 33321612 | QbD-driven formulation development and evaluation of topical hydrogel containing ketoconazole loaded cubosomes. | Mater Sci Eng C Mater Biol Appl | 2021 | https://conductscience.org/library/papers/33321612 | PubMed |
| 19 | 36883068 | In vitro Evaluation of Paliperidone Palmitate Loaded Cubosomes Effective for Nasal-to-Brain Delivery. | Int J Nanomedicine | 2023 | https://conductscience.org/library/papers/36883068 | PubMed |
| 20 | 36642250 | Nanotechnology based drug delivery systems for the treatment of anterior segment eye diseases. | J Control Release | 2023 | https://conductscience.org/library/papers/36642250 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42851891 | Advances in Cubosome-Based Transdermal Delivery: Structural Design, Manufacturing, and Engineering Strategies. | ACS Omega | 2026 | https://conductscience.org/library/papers/42851891 | PubMed |
| 41973189 | Cubosome-Based Nanocarriers in Cancer Therapy: Design Optimization, Analytical Characterization, and Translational Perspectives. | Ann Biomed Eng | 2026 | https://conductscience.org/library/papers/41973189 | PubMed |
| 41868188 | Formulation and Physicochemical Characterization of Capecitabine-Loaded Cubosomes for Enhanced Drug Delivery System. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41868188 | PubMed |
| 41126420 | Recent Advances in Artificial Intelligence and Nanotechnology-Driven Strategies for Diagnosis and Therapy of Ocular Diseases. | Curr Drug Deliv | 2026 | https://conductscience.org/library/papers/41126420 | PubMed |
| 41012534 | Stimuli-Responsive Cationic Lyotropic Liquid Crystalline Nanoparticles: Formulation Process, Physicochemical and Morphological Evaluation. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012534 | PubMed |
| 40871030 | Local Chemotherapy of Skin Pre-Neoplastic Lesions and Malignancies from the Perspective of Current Pharmaceutics. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40871030 | PubMed |
| 40727682 | Optimized buccoadhesive repaglinide-loaded cubogel: In-vitro characterization and in-vivo hypoglycemic activity in a streptozotocin-induced diabetic rat model. | Int J Pharm X | 2025 | https://conductscience.org/library/papers/40727682 | PubMed |
| 40284459 | Vesicular Carriers for Phytochemical Delivery: A Comprehensive Review of Techniques and Applications. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284459 | PubMed |
| 40045107 | Dual Drug Loaded Topical Cubosomal Gel Against Candida Albicans: An In Vitro and In Vivo Proof of Concept. | AAPS PharmSciTech | 2025 | https://conductscience.org/library/papers/40045107 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39022452
GET https://conductscience.org/api/papers/v1/39022452/references?page=2